A Dark Vector Cognition product

Item 16. Form 10-K Summary.

4K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary.

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MARSH & McLENNAN COMPANIES, INC.
Dated:February 10, 2025By/S/ JOHN Q. DOYLE
John Q. Doyle President and Chief Executive Officer

Each person whose signature appears below hereby constitutes and appoints Asha Amin and Connor Kuratek, and each of them singly, such person’s lawful attorneys-in-fact and agents, with full power to them and each of them to sign for such person, in the capacity indicated below, any and all amendments to this Annual Report on Form 10-K filed with the Securities and Exchange Commission.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated this 10th day of February, 2025.

NameTitleDate
/S/ JOHN Q. DOYLE John Q. DoyleDirector, President & Chief Executive OfficerFebruary 10, 2025
/S/ MARK C. MCGIVNEY Mark C. McGivneyChief Financial OfficerFebruary 10, 2025
/S/ STACY M. MILLS Stacy M. MillsVice President & Controller (Chief Accounting Officer)February 10, 2025
/S/ ANTHONY K. ANDERSON Anthony K. AndersonDirectorFebruary 10, 2025
/S/ OSCAR FANJUL Oscar FanjulDirectorFebruary 10, 2025
/S/ H. EDWARD HANWAY H. Edward HanwayDirectorFebruary 10, 2025
/S/ JUDITH HARTMANN Judith HartmannDirectorFebruary 10, 2025
/S/ DEBORAH C. HOPKINS Deborah C. HopkinsDirectorFebruary 10, 2025
/S/ TAMARA INGRAM Tamara IngramDirectorFebruary 10, 2025
/S/ JANE H. LUTE Jane H. LuteDirectorFebruary 10, 2025
/S/ STEVEN A. MILLS Steven A. MillsDirectorFebruary 10, 2025
/S/ MORTON O. SCHAPIRO Morton O. SchapiroDirectorFebruary 10, 2025
/S/ JAN SIEGMUND Jan SiegmundDirectorFebruary 10, 2025
/S/ LLOYD M. YATES Lloyd M. YatesDirectorFebruary 10, 2025

Previous: Item 15. Exhibits and Financial Statement Schedules. †